91 related articles for article (PubMed ID: 26482051)
1. The association between Metabolic Syndrome and serum levels of lipid peroxidation and interleukin-6 in Gorgan.
Sarbijani HM; Khoshnia M; Marjani A
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S86-9. PubMed ID: 26482051
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome.
Demircan N; Gurel A; Armutcu F; Unalacak M; Aktunc E; Atmaca H
Med Sci Monit; 2008 Feb; 14(2):CR97-101. PubMed ID: 18227768
[TBL] [Abstract][Full Text] [Related]
4. Relationship of oxidative stress with obesity and its role in obesity induced metabolic syndrome.
Sankhla M; Sharma TK; Mathur K; Rathor JS; Butolia V; Gadhok AK; Vardey SK; Sinha M; Kaushik GG
Clin Lab; 2012; 58(5-6):385-92. PubMed ID: 22783566
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome in type 2 diabetic subjects in Gorgan, Iran.
Marjani A; Mojerloo M
J Pak Med Assoc; 2011 May; 61(5):458-61. PubMed ID: 22204179
[TBL] [Abstract][Full Text] [Related]
6. Fasting hyperinsulinemia associates with increased sub-clinical inflammation in first-degree relatives normal glucose tolerant women independently of the metabolic syndrome.
Setola E; Monti LD; Lucotti P; Galluccio E; Oldani M; Bosi E; Piatti P
Diabetes Metab Res Rev; 2009 Oct; 25(7):639-46. PubMed ID: 19685554
[TBL] [Abstract][Full Text] [Related]
7. Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation.
Venturini D; Simão AN; Dichi I
Nutr Res; 2015 Sep; 35(9):759-65. PubMed ID: 26255193
[TBL] [Abstract][Full Text] [Related]
8. The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease.
Evans J; Collins M; Jennings C; van der Merwe L; Söderström I; Olsson T; Levitt NS; Lambert EV; Goedecke JH
Eur J Endocrinol; 2007 Nov; 157(5):633-40. PubMed ID: 17984243
[TBL] [Abstract][Full Text] [Related]
9. [Insulin resistance in patients with metabolic syndrome and cholelithiasis].
Mansurov KhKh; Mirodzhov GK; Mansurova FKh; Dustov AD; Mirzoeva PF; Mutikhova KhSh
Klin Med (Mosk); 2005; 83(7):48-51. PubMed ID: 16117426
[TBL] [Abstract][Full Text] [Related]
10. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome.
Choi KM; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH
Diabetes Res Clin Pract; 2007 Feb; 75(2):235-40. PubMed ID: 16872712
[TBL] [Abstract][Full Text] [Related]
11. Independent influence of insulin, catecholamines, and thyroid hormones on metabolic syndrome.
De Pergola G; Giorgino F; Benigno R; Guida P; Giorgino R
Obesity (Silver Spring); 2008 Nov; 16(11):2405-11. PubMed ID: 18719673
[TBL] [Abstract][Full Text] [Related]
12. Elevated advanced oxidation protein products (AOPPs) indicate metabolic risk in severely obese children.
Codoñer-Franch P; Tavárez-Alonso S; Murria-Estal R; Tortajada-Girbés M; Simó-Jordá R; Alonso-Iglesias E
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):237-43. PubMed ID: 20708392
[TBL] [Abstract][Full Text] [Related]
13. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance.
Hung J; McQuillan BM; Chapman CM; Thompson PL; Beilby JP
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1268-73. PubMed ID: 15790931
[TBL] [Abstract][Full Text] [Related]
14. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects.
Esteghamati A; Noshad S; Khalilzadeh O; Morteza A; Nazeri A; Meysamie A; Esteghamati A; Nakhjavani M
Arch Med Res; 2011 Apr; 42(3):244-51. PubMed ID: 21722822
[TBL] [Abstract][Full Text] [Related]
15. IL-6 gene expression in adipose tissue of postmenopausal women and its association with metabolic risk factors.
Sadashiv ; Tiwari S; Gupta V; Paul BN; Kumar S; Chandra A; Dhananjai S; Negi MP; Ghatak A
Mol Cell Endocrinol; 2015 Jan; 399():87-94. PubMed ID: 25301326
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.
Bortolasci CC; Vargas HO; Vargas Nunes SO; de Melo LG; de Castro MR; Moreira EG; Dodd S; Barbosa DS; Berk M; Maes M
J Affect Disord; 2015 Jul; 179():148-55. PubMed ID: 25863911
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma fractalkine levels are associated with higher levels of IL-6, Apo-B, LDL-C and insulin, but not with body composition in a large female twin sample.
Franco L; Williams FM; Trofimov S; Surdulescu G; Spector T; Livshits G
Metabolism; 2013 Aug; 62(8):1081-7. PubMed ID: 23477808
[TBL] [Abstract][Full Text] [Related]
18. Factor analysis of metabolic syndrome components in obese women.
Lafortuna CL; Adorni F; Agosti F; Sartorio A
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):233-41. PubMed ID: 17600693
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects.
Kim BJ; Kim TY; Koh JM; Kim HK; Park JY; Lee KU; Shong YK; Kim WB
Clin Endocrinol (Oxf); 2009 Jan; 70(1):152-60. PubMed ID: 18494864
[TBL] [Abstract][Full Text] [Related]
20. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
